New MASH drug trial aims to tame fatty liver disease
Disease control
Recruiting now
This early-stage trial tests an experimental drug called TGM-312-SC01 in healthy volunteers and people with MASH, a serious fatty liver disease. The goal is to check the drug's safety and how the body processes it. About 99 adults aged 18 to 70 will take part, with some receiving…
Phase: PHASE1, PHASE2 • Sponsor: Tangram Therapeutics Plc • Aim: Disease control
Last updated Jun 15, 2026 19:01 UTC